214 related articles for article (PubMed ID: 23923027)
1. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.
He X; Chen Z; Jia M; Zhao X
PLoS One; 2013; 8(7):e70858. PubMed ID: 23923027
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis.
Chen Z; He X; Xia W; Huang Q; Zhang Z; Ye J; Ni C; Wu P; Wu D; Xu J; Qiu F; Huang J
PLoS One; 2013; 8(12):e80337. PubMed ID: 24324596
[TBL] [Abstract][Full Text] [Related]
3. β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis.
Chen Z; He X; Jia M; Liu Y; Qu D; Wu D; Wu P; Ni C; Zhang Z; Ye J; Xu J; Huang J
PLoS One; 2013; 8(5):e63854. PubMed ID: 23717499
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
Yang YL; Chen MW; Xian L
PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478
[TBL] [Abstract][Full Text] [Related]
5. Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.
Chang K; Jiang L; Sun Y; Li H
Mol Diagn Ther; 2022 Jul; 26(4):397-409. PubMed ID: 35732878
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.
Chen J; Zhao J; Ma R; Lin H; Liang X; Cai X
PLoS One; 2014; 9(8):e103952. PubMed ID: 25093414
[TBL] [Abstract][Full Text] [Related]
7. Twist2 is a valuable prognostic biomarker for colorectal cancer.
Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH
World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
9. Correlation between non-metastatic protein 23 expression and clinicopathological features of colorectal cancer in Asians.
Fu JW; Chu XQ
Genet Mol Res; 2015 Dec; 14(4):15597-608. PubMed ID: 26634527
[TBL] [Abstract][Full Text] [Related]
10. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
11. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
[TBL] [Abstract][Full Text] [Related]
12. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
13. Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis.
Luo Y; Yu T; Zhang Q; Fu Q; Hu Y; Xiang M; Peng H; Zheng T; Lu L; Shi H
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29405291
[TBL] [Abstract][Full Text] [Related]
14. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer.
Peng J; Qi S; Wang P; Li W; Song L; Liu C; Li F
Future Oncol; 2016 Mar; 12(5):715-26. PubMed ID: 26653706
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
17. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of long non-coding RNA UCA1 in colorectal cancer: Results from a meta-analysis.
Liu X; Liu X; Qiao T; Chen W
Medicine (Baltimore); 2019 Nov; 98(48):e18031. PubMed ID: 31770217
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
